Principal Financial Group Inc. Buys 2,207 Shares of Axon Enterprise, Inc $AXON

Principal Financial Group Inc. increased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 2.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 89,138 shares of the biotechnology company’s stock after acquiring an additional 2,207 shares during the quarter. Principal Financial Group Inc. owned about 0.11% of Axon Enterprise worth $50,624,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vicus Capital increased its position in Axon Enterprise by 3.7% during the third quarter. Vicus Capital now owns 396 shares of the biotechnology company’s stock worth $284,000 after acquiring an additional 14 shares during the period. Evergreen Capital Management LLC increased its position in Axon Enterprise by 3.8% during the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock worth $342,000 after acquiring an additional 15 shares during the period. NorthCrest Asset Manangement LLC increased its holdings in Axon Enterprise by 5.4% in the 3rd quarter. NorthCrest Asset Manangement LLC now owns 313 shares of the biotechnology company’s stock valued at $223,000 after buying an additional 16 shares during the period. WPG Advisers LLC increased its holdings in Axon Enterprise by 9.8% in the 3rd quarter. WPG Advisers LLC now owns 190 shares of the biotechnology company’s stock valued at $136,000 after buying an additional 17 shares during the period. Finally, Monte Financial Group LLC increased its holdings in Axon Enterprise by 5.5% in the 3rd quarter. Monte Financial Group LLC now owns 325 shares of the biotechnology company’s stock valued at $233,000 after buying an additional 17 shares during the period. Institutional investors own 79.08% of the company’s stock.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported Q1 revenue of about $807 million, up 33.7% year over year, with EPS of $1.61 topping consensus by a penny and management lifting its 2026 revenue growth outlook to 30%-32% while targeting roughly $450 million in free cash flow. Axon Raises Guidance With AI Revenue Up 700%
• Positive Sentiment: Analysts largely remained constructive, with multiple firms reiterating bullish ratings and new/raised price targets, citing strong ARR growth, AI-driven demand, and durable growth prospects. Axon Earns Buy Rating on Robust ARR Growth, AI-Driven Demand, and Underappreciated Profitability
• Positive Sentiment: Baltimore approved a $153 million police-equipment contract, highlighting continued public-safety spending that could benefit Axon’s body cameras, Tasers, and related software ecosystem. Baltimore police to get upgraded body-worn cameras, Tasers after city approves $153 million contract
• Neutral Sentiment: Some coverage noted that Q1 earnings slightly missed estimates and tariff-related margin pressure offset part of the strong revenue growth, creating a mixed read on near-term profitability. AXON Q1 Earnings Miss Estimates on Tariff-Driven Margins
• Negative Sentiment: The stock also faced some valuation pressure from mixed analyst target moves, including at least one notable cut even as ratings stayed positive. Axon Enterprise price target lowered by Citizens JMP

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on AXON shares. Needham & Company LLC lowered their price target on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a report on Friday, February 20th. The Goldman Sachs Group set a $535.00 price target on shares of Axon Enterprise in a report on Thursday. Piper Sandler lowered their price target on shares of Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating on the stock in a report on Thursday. UBS Group lowered their price target on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a report on Thursday. Finally, TD Cowen lowered their price target on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a report on Wednesday, April 8th. Sixteen equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.

Axon Enterprise Stock Down 5.5%

Shares of NASDAQ:AXON opened at $403.54 on Friday. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $885.91. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.29 and a current ratio of 2.27. The company’s fifty day moving average is $451.93 and its 200-day moving average is $527.52. The company has a market capitalization of $32.51 billion, a PE ratio of 162.06, a P/E/G ratio of 9.11 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The company had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.91 million. During the same quarter in the previous year, the company earned $1.47 EPS. The firm’s revenue for the quarter was up 33.7% compared to the same quarter last year. Equities research analysts predict that Axon Enterprise, Inc will post 1.41 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Jeri Williams sold 157 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total value of $76,930.00. Following the sale, the director owned 1,159 shares in the company, valued at approximately $567,910. The trade was a 11.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Isaiah Fields sold 2,000 shares of the business’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the completion of the sale, the insider owned 55,588 shares in the company, valued at $29,740,135.88. This represents a 3.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 13,855 shares of company stock worth $7,109,828 in the last three months. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.